{'fraction_non_alphanumeric': 0.047961630695443645, 'fraction_numerical': 0.030375699440447643, 'mean_word_length': 4.63963963963964, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Serial plasma and urinary aluminum levels and tissue loading in preterm twins.

Serial plasma, urinary, and postmortem tissue aluminum levels were determined in 32-week, appropriate-for-gestational-age twins from 45 to 151 days postnatal age. Estimated total aluminum absorptions were 56.7 mg, and 28 mg, twin A and twin B, respectively. At autopsy, Twin A had a hypoplastic right kidney while Twin B had normal kidneys. Mean plasma aluminum levels (twin A, 34.2 micrograms/liter and twin B, 32.3 micrograms/liter) and urinary aluminum levels expressed as aluminum creatinine ratios (twin A, 11.3 and twin B, 8.5) were similar. These levels were elevated compared to normal plasma aluminum levels of 5.1 +/- 3.6 (1 SD) and urinary aluminum creatinine ratios of 0.64 +/- 0.75 (1 SD). Twin A had higher tissue aluminum levels than twin B in all tissues except for brain. Bone and liver aluminum contents for both twins were increased as compared to infants receiving short-term or no parenteral nutrition. We conclude; (1) tissue aluminum loading occurs in infants receiving aluminum-containing solutions, (2) plasma and urinary aluminum levels are poor predictors of tissue aluminum content, (3) enteral solutions may add significant aluminum exposure.